Related Experiment Video
Updated: Jun 28, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma
Marina Tshuikina1, Helena Jernberg-Wiklund, Kenneth Nilsson
1Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
Objective:
Multiple myeloma (MM) is presently an incurable malignant plasma cell tumor. The objective of this study was to investigate expression of the interferon regulatory factor family (IRF1-9) and the potential role of DNA methylation in silencing IRF genes in MM cell lines and purified MM cells from patients.
Materials And Methods:
Using a panel of 13 human MM cell lines and purified CD138+ cells from nine MM patients, expression of IRF genes was investigated by quantitative reverse transcriptase polymerase chain reaction and Western blot. DNA methylation of the interferon consensus sequence-binding protein (ICSBP/IRF8) gene was measured using pyrosequencing, and the effect of promoter methylation on expression was analyzed by in vitro methylation of a cloned ICSBP/IRF8 promoter, and treatment of MM cells with 5-aza-2'-deoxycytidine (DAC).
Results:
Eight of thirteen of the MM cell lines were found to lack ICSBP/IRF8 expression, associated with hypermethylation of the CpG island in the ICSBP/IRF8 promoter. We also found that ICSBP/IRF8 was significantly underexpressed in primary MM cells, whereas the ICSBP/IRF8 promoter was methylated in only one of nine of primary purified CD138+ MM samples. DAC-mediated demethylation restored endogenous ICSBP/IRF8 expression, whereas in vitro methylation silenced the promoter.
Conclusion:
Expression of the ICSBP/IRF8 gene is silenced in a majority of MM cell lines and primary CD138+ MM cells. DNA methylation of the ICSBP/IRF8 gene is a frequent event in MM cell lines, but silencing is also observed in the absence of methylation. These results suggest that silencing of ICSBP/IRF8 expression, by DNA methylation or other epigenetic mechanisms, may be associated with the malignant phenotype of MM.
Insights
Silencing of interferon regulatory factor 8 (IRF8) occurs in most multiple myeloma cell lines and patient cells, often due to DNA methylation. This IRF8 gene silencing may contribute to the malignancy of multiple myeloma.
Area of Science:
- Hematology
- Molecular Biology
- Epigenetics
Background:
- Multiple myeloma (MM) is an incurable plasma cell malignancy.
- The interferon regulatory factor (IRF) family's role in MM is not fully understood.
- Epigenetic modifications, such as DNA methylation, can regulate gene expression in cancer.
Purpose of the Study:
- To investigate the expression of IRF family members (IRF1-9) in multiple myeloma.
- To determine the role of DNA methylation in silencing IRF genes, particularly interferon consensus sequence-binding protein (ICSBP/IRF8), in MM.
- To analyze the association between IRF8 gene silencing and the malignant phenotype of MM.
Main Methods:
- Quantitative reverse transcriptase polymerase chain reaction and Western blot were used to assess IRF gene expression in 13 MM cell lines and primary MM cells.
- Pyrosequencing analyzed DNA methylation of the ICSBP/IRF8 promoter.
- In vitro methylation and 5-aza-2'-deoxycytidine (DAC) treatment were employed to study the effect of methylation on ICSBP/IRF8 expression.
Main Results:
- ICSBP/IRF8 expression was absent in 8/13 MM cell lines, correlating with promoter hypermethylation.
- ICSBP/IRF8 was significantly underexpressed in primary MM cells, with methylation present in only one sample.
- DAC treatment restored ICSBP/IRF8 expression, while in vitro methylation silenced it.
Conclusions:
- ICSBP/IRF8 gene expression is frequently silenced in multiple myeloma cell lines and primary cells.
- DNA methylation is a common mechanism for ICSBP/IRF8 silencing in MM cell lines, but other epigenetic mechanisms also contribute.
- Silencing of ICSBP/IRF8, via DNA methylation or other epigenetic means, may be linked to the malignant characteristics of multiple myeloma.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
MicroRNAs
MicroRNAs
Experimental RNAi
Abnormal Proliferation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

